SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001829126-23-002437
Filing Date
2023-03-31
Accepted
2023-03-30 17:35:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A appliedtherapeutics_sc13ga.htm SC 13G/A 72820
  Complete submission text file 0001829126-23-002437.txt   74301
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Subject) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91017 | Film No.: 23781990
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1800 AVENUE OF THE STARS, 3RD FLOOR LOS ANGELES CA 90067
Business Address 1800 AVENUE OF THE STARS, 3RD FLOOR LOS ANGELES CA 90067 206-602-9246
Propel Bio Partners L.P. (Filed by) CIK: 0001917402 (see all company filings)

IRS No.: 874596888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A